+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Automated Parallel Peptide Synthesizer Market - Global Forecast to 2030- Product Image
Automated Parallel Peptide Synthesizer Market - Global Forecast to 2030- Product Image
New

Automated Parallel Peptide Synthesizer Market - Global Forecast to 2030

  • PDF Icon

    Report

  • 192 Pages
  • May 2025
  • Region: Global
  • 360iResearch™
  • ID: 6081040
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The automated parallel peptide synthesizer market has rapidly emerged as a cornerstone technology enabling high-throughput peptide production for research, diagnostic and therapeutic applications. With increasing demand for streamlined workflows, reproducibility and scalability, organizations across academic, pharmaceutical and biotech sectors are investing heavily in automated platforms that integrate cutting-edge solid phase and liquid phase synthesis methods. As peptide-based drugs gain traction in oncology, infectious disease and metabolic disorder treatments, the ability to produce long, medium and short peptides with precision and speed is transforming discovery-to-development timelines. Furthermore, advances in continuous-flow reactors and convergent coupling techniques are redefining efficiency benchmarks. This introduction lays the foundation for understanding the dynamic forces shaping market growth, regulatory considerations, and competitive dynamics driving innovation in peptide synthesis technology.

Transformative shifts redefining peptide synthesizer capabilities

Over the past five years, the peptide synthesis landscape has undergone transformative shifts driven by convergence of automation, miniaturization and digital integration. Platforms once reliant on manual synthesizers have given way to fully automated systems that combine real-time monitoring, AI-driven process optimization and modular reactor configurations. Continuous-flow reactors now rival batch processes in throughput, while solid phase synthesis instruments leverage improved resin chemistries to boost coupling efficiency. Simultaneously, liquid phase peptide synthesis has reemerged for select applications requiring rapid coupling in automated equipment. The integration of data analytics ensures every synthesis run generates actionable insights, enabling adaptive optimization of reagent usage and reaction parameters. Collectively, these technological and operational advancements are democratizing access to peptide libraries and accelerating time-to-insight for both small academic labs and global pharmaceutical firms.

Assessing the cumulative impact of United States tariffs in 2025

United States tariffs introduced in early 2025 have imposed a cumulative impact on imported peptide synthesizer components, consumables and critical reagents. Equipment manufacturers relying on overseas supply chains for resins, solvents and specialized hardware have encountered elevated input costs, which in turn have translated into higher capital expenditure for end users. While some domestic producers have capitalized on near-shoring opportunities to mitigate tariff pressures, others are renegotiating supplier contracts or exploring alternative resin chemistries to manage cost increases. Academic institutions face tightened budgets for hands-on training laboratories, and biopharmaceutical R&D teams are reassessing instrument upgrade timelines. Nonetheless, offsetting measures-such as collaborative research agreements with reagent suppliers and increased adoption of continuous-flow modules to reduce per-run reagent waste-are helping stakeholders navigate the tariff landscape without compromising innovation velocity.

Key segmentation insights across industry, technology and application

Insight into market segmentation reveals distinct demand drivers across end user industries. Academic institutions prioritize curriculum development and hands-on training laboratories, often forging research collaborations to access cutting-edge synthesizers. Pharmaceutical companies focus heavily on drug discovery and development pipelines, deploying automated platforms for quality control and high-throughput screening. Research institutes channel resources into antibody production, biotechnology research and molecular biology studies, leveraging peptide libraries to probe protein interactions.

The distinction between liquid phase and solid phase synthesizers informs technology adoption strategies. Liquid phase peptide synthesis systems, available in both automated and conventional methods, cater to rapid coupling needs for peptide fragments, while solid phase platforms-whether employing batch reactors or continuous-flow reactors-serve high-volume peptide production and complex sequence assemblies.

Applications underscore the versatility of peptide synthesizers. Assay development and biomarker detection rely on diagnostic peptides, whereas research peptides drive structure-activity relationship studies and protein interaction investigations. Therapeutic peptides focused on cancer treatment, infectious diseases and metabolic disorders demand stringent purity standards and scalable synthesis protocols.

From a product perspective, consumables such as reagents, resins and solvents remain indispensable, with instruments spanning manual synthesizers, semi-automated systems and fully automated synthesizers enabling flexible deployment across lab sizes.

Peptide length segmentation highlights that short peptides (2-20 amino acids) dominate high-throughput screening, medium peptides (21-50 amino acids) support epitope mapping and vaccine research, and long peptides (more than 50 amino acids) address complex therapeutic targets.

Mode of synthesis further differentiates market preferences: sequential and convergent coupling methods underpin multiple step synthesis workflows, whereas single step resin coupling streamlines simpler peptide assemblies.

Finally, peptide type influences system requirements. Cyclic peptides, including stapled variants, drive demand for precision cyclization protocols. Unmodified linear peptides remain foundational for basic research, while peptidomimetics-spanning protein mimetics and small molecule mimetics-require specialized chemistries supported by advanced synthesizer modules.

Regional dynamics shaping market adoption and growth

The Americas region, led by the United States and Canada, commands a significant share driven by robust pharmaceutical R&D investments and well-established academic research networks. Demand is further buoyed by biotech hubs focusing on peptide-based therapeutics and diagnostics.

Europe, Middle East and Africa combine mature markets in Western Europe with emerging research ecosystems in the Middle East and Africa. Key drivers include government initiatives to boost life sciences innovation, cross-border collaborations and rising adoption of automated laboratory infrastructure.

Asia-Pacific is experiencing rapid expansion, underpinned by rising healthcare expenditures in China, Japan and South Korea, as well as burgeoning biotech clusters in India and Australia. Local manufacturing capacities and favorable regulatory reforms are accelerating instrument deployments and consumable consumption.

Competitive outlook and key company insights

Several established and emerging players define the competitive landscape. AAPPTec and Advanced ChemTech are recognized for their customizable synthesizer configurations that accommodate diverse peptide lengths and coupling strategies. AG Scientific and AminoTech SA excel in supplying high-purity reagents, resins and solvents tailored for liquid phase and solid phase synthesis. BGI Genomics and GenScript Biotech Corporation leverage integrated service models, offering peptide synthesis alongside bioinformatics support for structure-activity relationship studies.

Instrument specialists such as Biotage, CEM Corporation and Gilson Inc. emphasize continuous-flow reactor integration and AI-enabled process analytics. CS Bio and EMD Millipore provide modular platforms that support both manual and semi-automated workflows, appealing to academic labs with variable throughput needs.

Gyros Protein Technologies and Intavis Bioanalytical Instruments AG focus on microplate-based automation, enhancing capacity for diagnostic peptide screening. JPT Peptide Technologies and Peptides International Inc. deliver contract synthesis services, addressing high-complexity therapeutic peptide portfolios. Kinexus Bioinformatics Corporation and PSI (Protein Synthesizer Inc.) offer end-to-end solutions encompassing instrument hardware, software and bioinformatics integration.

Sartorius Stedim Biotech and Thermo Fisher Scientific round out the market with comprehensive automation ecosystems, combining fully automated synthesizers, reagent kits and cloud-based data management to support seamless scalability from research to production.

Actionable recommendations for industry leaders

Industry leaders can unlock competitive advantage by adopting several strategic initiatives. First, investing in modular synthesizer architectures that support both continuous-flow and batch processes will provide flexibility to meet evolving research requirements. Second, forging strategic partnerships with reagent and resin suppliers can mitigate supply chain disruptions and optimize input costs amid tariff volatility. Third, integrating AI-driven analytics and real-time monitoring tools into synthesis workflows will enhance process transparency, reduce cycle times and improve yield consistency. Fourth, expanding service offerings to include contract synthesis and bioinformatics support can capture value across the peptide development lifecycle. Finally, prioritizing sustainability through reagent recycling protocols and energy-efficient reactor designs will resonate with stakeholders seeking to minimize environmental impact while maintaining productivity.

Conclusion: navigating growth and innovation in peptide synthesis

In conclusion, the automated parallel peptide synthesizer market is poised for sustained growth, fueled by technological advancements, expanding application domains and strategic realignment in response to tariff dynamics. Robust segmentation insights reveal tailored opportunities across academic, pharmaceutical and research sectors, while regional analysis highlights divergent growth trajectories in the Americas, EMEA and Asia-Pacific. Leading companies continue to innovate through modular designs, integrated analytics and comprehensive service models, setting the stage for a new era of peptide synthesis efficiency and scalability. By embracing strategic partnerships, AI-enabled optimization and sustainable practices, stakeholders can navigate emerging challenges and capitalize on the transformative potential of peptide automation.

Market Segmentation & Coverage

This research report categorizes the Automated Parallel Peptide Synthesizer Market to forecast the revenues and analyze trends in each of the following sub-segmentations:

  • Academic Institutions
    • Curriculum Development
    • Hands-On Training Laboratories
    • Research Collaborations
  • Pharmaceutical Companies
    • Drug Development
    • Drug Discovery
    • Quality Control
  • Research Institutes
    • Antibody Production
    • Biotechnology Research
    • Molecular Biology Studies
  • Liquid Phase Peptide Synthesis
    • Automated Equipment
    • Conventional Methods
  • Solid Phase Peptide Synthesis
    • Batch Reactor
    • Continuous-Flow Reactor
  • Diagnostic Peptides
    • Assay Development
    • Biomarker Detection
  • Research Peptides
    • Protein Interaction Studies
    • Structure-Activity Relationship Studies
  • Therapeutic Peptides
    • Cancer Treatment
    • Infectious Diseases
    • Metabolic Disorders
  • Consumables
    • Reagents
    • Resins
    • Solvents
  • Instruments
    • Fully Automated Synthesizers
    • Manual Synthesizers
    • Semi-Automated Synthesizers
  • Long Peptides
    • More Than 50 Amino Acids
  • Medium Peptides
    • 21-50 Amino Acids
  • Short Peptides
    • 2-20 Amino Acids
  • Multiple Step Synthesis
    • Convergent Coupling
    • Sequential Coupling
  • Single Step Synthesis
    • Resin Coupling
  • Cyclic Peptides
    • Stapled Peptides
  • Linear Peptides
    • Unmodified Linear Peptides
  • Peptidomimetics
    • Protein Mimetics
    • Small Molecule Mimetics

This research report categorizes the Automated Parallel Peptide Synthesizer Market to forecast the revenues and analyze trends in each of the following sub-regions:

  • Americas
    • Argentina
    • Brazil
    • Canada
    • Mexico
    • United States
      • California
      • Florida
      • Illinois
      • New York
      • Ohio
      • Pennsylvania
      • Texas
  • Asia-Pacific
    • Australia
    • China
    • India
    • Indonesia
    • Japan
    • Malaysia
    • Philippines
    • Singapore
    • South Korea
    • Taiwan
    • Thailand
    • Vietnam
  • Europe, Middle East & Africa
    • Denmark
    • Egypt
    • Finland
    • France
    • Germany
    • Israel
    • Italy
    • Netherlands
    • Nigeria
    • Norway
    • Poland
    • Qatar
    • Russia
    • Saudi Arabia
    • South Africa
    • Spain
    • Sweden
    • Switzerland
    • Turkey
    • United Arab Emirates
    • United Kingdom

This research report categorizes the Automated Parallel Peptide Synthesizer Market to delves into recent significant developments and analyze trends in each of the following companies:

  • AAPPTec
  • Advanced ChemTech
  • AG Scientific
  • AminoTech SA
  • BGI Genomics
  • Biotage
  • CEM Corporation
  • CS Bio
  • EMD Millipore
  • GenScript Biotech Corporation
  • Gilson Inc.
  • Gyros Protein Technologies
  • Intavis Bioanalytical Instruments AG
  • JPT Peptide Technologies
  • Kinexus Bioinformatics Corporation
  • Peptides International Inc.
  • PSI (Protein Synthesizer Inc.)
  • Sartorius Stedim Biotech
  • Thermo Fisher Scientific

This product will be delivered within 1-3 business days.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Automated Parallel Peptide Synthesizer Market, by End User Industry
8.1. Introduction
8.2. Academic Institutions
8.2.1. Curriculum Development
8.2.2. Hands-On Training Laboratories
8.2.3. Research Collaborations
8.3. Pharmaceutical Companies
8.3.1. Drug Development
8.3.2. Drug Discovery
8.3.3. Quality Control
8.4. Research Institutes
8.4.1. Antibody Production
8.4.2. Biotechnology Research
8.4.3. Molecular Biology Studies
9. Automated Parallel Peptide Synthesizer Market, by Technology Type
9.1. Introduction
9.2. Liquid Phase Peptide Synthesis
9.2.1. Automated Equipment
9.2.2. Conventional Methods
9.3. Solid Phase Peptide Synthesis
9.3.1. Batch Reactor
9.3.2. Continuous-Flow Reactor
10. Automated Parallel Peptide Synthesizer Market, by Application
10.1. Introduction
10.2. Diagnostic Peptides
10.2.1. Assay Development
10.2.2. Biomarker Detection
10.3. Research Peptides
10.3.1. Protein Interaction Studies
10.3.2. Structure-Activity Relationship Studies
10.4. Therapeutic Peptides
10.4.1. Cancer Treatment
10.4.2. Infectious Diseases
10.4.3. Metabolic Disorders
11. Automated Parallel Peptide Synthesizer Market, by Product Type
11.1. Introduction
11.2. Consumables
11.2.1. Reagents
11.2.2. Resins
11.2.3. Solvents
11.3. Instruments
11.3.1. Fully Automated Synthesizers
11.3.2. Manual Synthesizers
11.3.3. Semi-Automated Synthesizers
12. Automated Parallel Peptide Synthesizer Market, by Peptide Length
12.1. Introduction
12.2. Long Peptides
12.2.1. More Than 50 Amino Acids
12.3. Medium Peptides
12.3.1. 21-50 Amino Acids
12.4. Short Peptides
12.4.1. 2-20 Amino Acids
13. Automated Parallel Peptide Synthesizer Market, by Mode of Synthesis
13.1. Introduction
13.2. Multiple Step Synthesis
13.2.1. Convergent Coupling
13.2.2. Sequential Coupling
13.3. Single Step Synthesis
13.3.1. Resin Coupling
14. Automated Parallel Peptide Synthesizer Market, by Peptide Type
14.1. Introduction
14.2. Cyclic Peptides
14.2.1. Stapled Peptides
14.3. Linear Peptides
14.3.1. Unmodified Linear Peptides
14.4. Peptidomimetics
14.4.1. Protein Mimetics
14.4.2. Small Molecule Mimetics
15. Americas Automated Parallel Peptide Synthesizer Market
15.1. Introduction
15.2. Argentina
15.3. Brazil
15.4. Canada
15.5. Mexico
15.6. United States
16. Asia-Pacific Automated Parallel Peptide Synthesizer Market
16.1. Introduction
16.2. Australia
16.3. China
16.4. India
16.5. Indonesia
16.6. Japan
16.7. Malaysia
16.8. Philippines
16.9. Singapore
16.10. South Korea
16.11. Taiwan
16.12. Thailand
16.13. Vietnam
17. Europe, Middle East & Africa Automated Parallel Peptide Synthesizer Market
17.1. Introduction
17.2. Denmark
17.3. Egypt
17.4. Finland
17.5. France
17.6. Germany
17.7. Israel
17.8. Italy
17.9. Netherlands
17.10. Nigeria
17.11. Norway
17.12. Poland
17.13. Qatar
17.14. Russia
17.15. Saudi Arabia
17.16. South Africa
17.17. Spain
17.18. Sweden
17.19. Switzerland
17.20. Turkey
17.21. United Arab Emirates
17.22. United Kingdom
18. Competitive Landscape
18.1. Market Share Analysis, 2024
18.2. FPNV Positioning Matrix, 2024
18.3. Competitive Analysis
18.3.1. AAPPTec
18.3.2. Advanced ChemTech
18.3.3. AG Scientific
18.3.4. AminoTech SA
18.3.5. BGI Genomics
18.3.6. Biotage
18.3.7. CEM Corporation
18.3.8. CS Bio
18.3.9. EMD Millipore
18.3.10. GenScript Biotech Corporation
18.3.11. Gilson Inc.
18.3.12. Gyros Protein Technologies
18.3.13. Intavis Bioanalytical Instruments AG
18.3.14. JPT Peptide Technologies
18.3.15. Kinexus Bioinformatics Corporation
18.3.16. Peptides International Inc.
18.3.17. PSI (Protein Synthesizer Inc.)
18.3.18. Sartorius Stedim Biotech
18.3.19. Thermo Fisher Scientific
19. ResearchAI
20. ResearchStatistics
21. ResearchContacts
22. ResearchArticles
23. Appendix
List of Figures
FIGURE 1. AUTOMATED PARALLEL PEPTIDE SYNTHESIZER MARKET MULTI-CURRENCY
FIGURE 2. AUTOMATED PARALLEL PEPTIDE SYNTHESIZER MARKET MULTI-LANGUAGE
FIGURE 3. AUTOMATED PARALLEL PEPTIDE SYNTHESIZER MARKET RESEARCH PROCESS
FIGURE 4. GLOBAL AUTOMATED PARALLEL PEPTIDE SYNTHESIZER MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 5. GLOBAL AUTOMATED PARALLEL PEPTIDE SYNTHESIZER MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 6. GLOBAL AUTOMATED PARALLEL PEPTIDE SYNTHESIZER MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL AUTOMATED PARALLEL PEPTIDE SYNTHESIZER MARKET SIZE, BY END USER INDUSTRY, 2024 VS 2030 (%)
FIGURE 8. GLOBAL AUTOMATED PARALLEL PEPTIDE SYNTHESIZER MARKET SIZE, BY END USER INDUSTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL AUTOMATED PARALLEL PEPTIDE SYNTHESIZER MARKET SIZE, BY TECHNOLOGY TYPE, 2024 VS 2030 (%)
FIGURE 10. GLOBAL AUTOMATED PARALLEL PEPTIDE SYNTHESIZER MARKET SIZE, BY TECHNOLOGY TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL AUTOMATED PARALLEL PEPTIDE SYNTHESIZER MARKET SIZE, BY APPLICATION, 2024 VS 2030 (%)
FIGURE 12. GLOBAL AUTOMATED PARALLEL PEPTIDE SYNTHESIZER MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL AUTOMATED PARALLEL PEPTIDE SYNTHESIZER MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2030 (%)
FIGURE 14. GLOBAL AUTOMATED PARALLEL PEPTIDE SYNTHESIZER MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. GLOBAL AUTOMATED PARALLEL PEPTIDE SYNTHESIZER MARKET SIZE, BY PEPTIDE LENGTH, 2024 VS 2030 (%)
FIGURE 16. GLOBAL AUTOMATED PARALLEL PEPTIDE SYNTHESIZER MARKET SIZE, BY PEPTIDE LENGTH, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. GLOBAL AUTOMATED PARALLEL PEPTIDE SYNTHESIZER MARKET SIZE, BY MODE OF SYNTHESIS, 2024 VS 2030 (%)
FIGURE 18. GLOBAL AUTOMATED PARALLEL PEPTIDE SYNTHESIZER MARKET SIZE, BY MODE OF SYNTHESIS, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. GLOBAL AUTOMATED PARALLEL PEPTIDE SYNTHESIZER MARKET SIZE, BY PEPTIDE TYPE, 2024 VS 2030 (%)
FIGURE 20. GLOBAL AUTOMATED PARALLEL PEPTIDE SYNTHESIZER MARKET SIZE, BY PEPTIDE TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. AMERICAS AUTOMATED PARALLEL PEPTIDE SYNTHESIZER MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 22. AMERICAS AUTOMATED PARALLEL PEPTIDE SYNTHESIZER MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. UNITED STATES AUTOMATED PARALLEL PEPTIDE SYNTHESIZER MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 24. UNITED STATES AUTOMATED PARALLEL PEPTIDE SYNTHESIZER MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 25. ASIA-PACIFIC AUTOMATED PARALLEL PEPTIDE SYNTHESIZER MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 26. ASIA-PACIFIC AUTOMATED PARALLEL PEPTIDE SYNTHESIZER MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 27. EUROPE, MIDDLE EAST & AFRICA AUTOMATED PARALLEL PEPTIDE SYNTHESIZER MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 28. EUROPE, MIDDLE EAST & AFRICA AUTOMATED PARALLEL PEPTIDE SYNTHESIZER MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 29. AUTOMATED PARALLEL PEPTIDE SYNTHESIZER MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 30. AUTOMATED PARALLEL PEPTIDE SYNTHESIZER MARKET, FPNV POSITIONING MATRIX, 2024
List of Tables
TABLE 1. AUTOMATED PARALLEL PEPTIDE SYNTHESIZER MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL AUTOMATED PARALLEL PEPTIDE SYNTHESIZER MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL AUTOMATED PARALLEL PEPTIDE SYNTHESIZER MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GLOBAL AUTOMATED PARALLEL PEPTIDE SYNTHESIZER MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 6. GLOBAL AUTOMATED PARALLEL PEPTIDE SYNTHESIZER MARKET SIZE, BY END USER INDUSTRY, 2018-2030 (USD MILLION)
TABLE 7. GLOBAL AUTOMATED PARALLEL PEPTIDE SYNTHESIZER MARKET SIZE, BY ACADEMIC INSTITUTIONS, BY REGION, 2018-2030 (USD MILLION)
TABLE 8. GLOBAL AUTOMATED PARALLEL PEPTIDE SYNTHESIZER MARKET SIZE, BY CURRICULUM DEVELOPMENT, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. GLOBAL AUTOMATED PARALLEL PEPTIDE SYNTHESIZER MARKET SIZE, BY HANDS-ON TRAINING LABORATORIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. GLOBAL AUTOMATED PARALLEL PEPTIDE SYNTHESIZER MARKET SIZE, BY RESEARCH COLLABORATIONS, BY REGION, 2018-2030 (USD MILLION)
TABLE 11. GLOBAL AUTOMATED PARALLEL PEPTIDE SYNTHESIZER MARKET SIZE, BY ACADEMIC INSTITUTIONS, 2018-2030 (USD MILLION)
TABLE 12. GLOBAL AUTOMATED PARALLEL PEPTIDE SYNTHESIZER MARKET SIZE, BY PHARMACEUTICAL COMPANIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. GLOBAL AUTOMATED PARALLEL PEPTIDE SYNTHESIZER MARKET SIZE, BY DRUG DEVELOPMENT, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. GLOBAL AUTOMATED PARALLEL PEPTIDE SYNTHESIZER MARKET SIZE, BY DRUG DISCOVERY, BY REGION, 2018-2030 (USD MILLION)
TABLE 15. GLOBAL AUTOMATED PARALLEL PEPTIDE SYNTHESIZER MARKET SIZE, BY QUALITY CONTROL, BY REGION, 2018-2030 (USD MILLION)
TABLE 16. GLOBAL AUTOMATED PARALLEL PEPTIDE SYNTHESIZER MARKET SIZE, BY PHARMACEUTICAL COMPANIES, 2018-2030 (USD MILLION)
TABLE 17. GLOBAL AUTOMATED PARALLEL PEPTIDE SYNTHESIZER MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2018-2030 (USD MILLION)
TABLE 18. GLOBAL AUTOMATED PARALLEL PEPTIDE SYNTHESIZER MARKET SIZE, BY ANTIBODY PRODUCTION, BY REGION, 2018-2030 (USD MILLION)
TABLE 19. GLOBAL AUTOMATED PARALLEL PEPTIDE SYNTHESIZER MARKET SIZE, BY BIOTECHNOLOGY RESEARCH, BY REGION, 2018-2030 (USD MILLION)
TABLE 20. GLOBAL AUTOMATED PARALLEL PEPTIDE SYNTHESIZER MARKET SIZE, BY MOLECULAR BIOLOGY STUDIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 21. GLOBAL AUTOMATED PARALLEL PEPTIDE SYNTHESIZER MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
TABLE 22. GLOBAL AUTOMATED PARALLEL PEPTIDE SYNTHESIZER MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2030 (USD MILLION)
TABLE 23. GLOBAL AUTOMATED PARALLEL PEPTIDE SYNTHESIZER MARKET SIZE, BY LIQUID PHASE PEPTIDE SYNTHESIS, BY REGION, 2018-2030 (USD MILLION)
TABLE 24. GLOBAL AUTOMATED PARALLEL PEPTIDE SYNTHESIZER MARKET SIZE, BY AUTOMATED EQUIPMENT, BY REGION, 2018-2030 (USD MILLION)
TABLE 25. GLOBAL AUTOMATED PARALLEL PEPTIDE SYNTHESIZER MARKET SIZE, BY CONVENTIONAL METHODS, BY REGION, 2018-2030 (USD MILLION)
TABLE 26. GLOBAL AUTOMATED PARALLEL PEPTIDE SYNTHESIZER MARKET SIZE, BY LIQUID PHASE PEPTIDE SYNTHESIS, 2018-2030 (USD MILLION)
TABLE 27. GLOBAL AUTOMATED PARALLEL PEPTIDE SYNTHESIZER MARKET SIZE, BY SOLID PHASE PEPTIDE SYNTHESIS, BY REGION, 2018-2030 (USD MILLION)
TABLE 28. GLOBAL AUTOMATED PARALLEL PEPTIDE SYNTHESIZER MARKET SIZE, BY BATCH REACTOR, BY REGION, 2018-2030 (USD MILLION)
TABLE 29. GLOBAL AUTOMATED PARALLEL PEPTIDE SYNTHESIZER MARKET SIZE, BY CONTINUOUS-FLOW REACTOR, BY REGION, 2018-2030 (USD MILLION)
TABLE 30. GLOBAL AUTOMATED PARALLEL PEPTIDE SYNTHESIZER MARKET SIZE, BY SOLID PHASE PEPTIDE SYNTHESIS, 2018-2030 (USD MILLION)
TABLE 31. GLOBAL AUTOMATED PARALLEL PEPTIDE SYNTHESIZER MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 32. GLOBAL AUTOMATED PARALLEL PEPTIDE SYNTHESIZER MARKET SIZE, BY DIAGNOSTIC PEPTIDES, BY REGION, 2018-2030 (USD MILLION)
TABLE 33. GLOBAL AUTOMATED PARALLEL PEPTIDE SYNTHESIZER MARKET SIZE, BY ASSAY DEVELOPMENT, BY REGION, 2018-2030 (USD MILLION)
TABLE 34. GLOBAL AUTOMATED PARALLEL PEPTIDE SYNTHESIZER MARKET SIZE, BY BIOMARKER DETECTION, BY REGION, 2018-2030 (USD MILLION)
TABLE 35. GLOBAL AUTOMATED PARALLEL PEPTIDE SYNTHESIZER MARKET SIZE, BY DIAGNOSTIC PEPTIDES, 2018-2030 (USD MILLION)
TABLE 36. GLOBAL AUTOMATED PARALLEL PEPTIDE SYNTHESIZER MARKET SIZE, BY RESEARCH PEPTIDES, BY REGION, 2018-2030 (USD MILLION)
TABLE 37. GLOBAL AUTOMATED PARALLEL PEPTIDE SYNTHESIZER MARKET SIZE, BY PROTEIN INTERACTION STUDIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 38. GLOBAL AUTOMATED PARALLEL PEPTIDE SYNTHESIZER MARKET SIZE, BY STRUCTURE-ACTIVITY RELATIONSHIP STUDIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 39. GLOBAL AUTOMATED PARALLEL PEPTIDE SYNTHESIZER MARKET SIZE, BY RESEARCH PEPTIDES, 2018-2030 (USD MILLION)
TABLE 40. GLOBAL AUTOMATED PARALLEL PEPTIDE SYNTHESIZER MARKET SIZE, BY THERAPEUTIC PEPTIDES, BY REGION, 2018-2030 (USD MILLION)
TABLE 41. GLOBAL AUTOMATED PARALLEL PEPTIDE SYNTHESIZER MARKET SIZE, BY CANCER TREATMENT, BY REGION, 2018-2030 (USD MILLION)
TABLE 42. GLOBAL AUTOMATED PARALLEL PEPTIDE SYNTHESIZER MARKET SIZE, BY INFECTIOUS DISEASES, BY REGION, 2018-2030 (USD MILLION)
TABLE 43. GLOBAL AUTOMATED PARALLEL PEPTIDE SYNTHESIZER MARKET SIZE, BY METABOLIC DISORDERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 44. GLOBAL AUTOMATED PARALLEL PEPTIDE SYNTHESIZER MARKET SIZE, BY THERAPEUTIC PEPTIDES, 2018-2030 (USD MILLION)
TABLE 45. GLOBAL AUTOMATED PARALLEL PEPTIDE SYNTHESIZER MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 46. GLOBAL AUTOMATED PARALLEL PEPTIDE SYNTHESIZER MARKET SIZE, BY CONSUMABLES, BY REGION, 2018-2030 (USD MILLION)
TABLE 47. GLOBAL AUTOMATED PARALLEL PEPTIDE SYNTHESIZER MARKET SIZE, BY REAGENTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 48. GLOBAL AUTOMATED PARALLEL PEPTIDE SYNTHESIZER MARKET SIZE, BY RESINS, BY REGION, 2018-2030 (USD MILLION)
TABLE 49. GLOBAL AUTOMATED PARALLEL PEPTIDE SYNTHESIZER MARKET SIZE, BY SOLVENTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 50. GLOBAL AUTOMATED PARALLEL PEPTIDE SYNTHESIZER MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 51. GLOBAL AUTOMATED PARALLEL PEPTIDE SYNTHESIZER MARKET SIZE, BY INSTRUMENTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 52. GLOBAL AUTOMATED PARALLEL PEPTIDE SYNTHESIZER MARKET SIZE, BY FULLY AUTOMATED SYNTHESIZERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 53. GLOBAL AUTOMATED PARALLEL PEPTIDE SYNTHESIZER MARKET SIZE, BY MANUAL SYNTHESIZERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 54. GLOBAL AUTOMATED PARALLEL PEPTIDE SYNTHESIZER MARKET SIZE, BY SEMI-AUTOMATED SYNTHESIZERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 55. GLOBAL AUTOMATED PARALLEL PEPTIDE SYNTHESIZER MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 56. GLOBAL AUTOMATED PARALLEL PEPTIDE SYNTHESIZER MARKET SIZE, BY PEPTIDE LENGTH, 2018-2030 (USD MILLION)
TABLE 57. GLOBAL AUTOMATED PARALLEL PEPTIDE SYNTHESIZER MARKET SIZE, BY LONG PEPTIDES, BY REGION, 2018-2030 (USD MILLION)
TABLE 58. GLOBAL AUTOMATED PARALLEL PEPTIDE SYNTHESIZER MARKET SIZE, BY MORE THAN 50 AMINO ACIDS, BY REGION, 2018-2030 (USD MILLION)
TABLE 59. GLOBAL AUTOMATED PARALLEL PEPTIDE SYNTHESIZER MARKET SIZE, BY LONG PEPTIDES, 2018-2030 (USD MILLION)
TABLE 60. GLOBAL AUTOMATED PARALLEL PEPTIDE SYNTHESIZER MARKET SIZE, BY MEDIUM PEPTIDES, BY REGION, 2018-2030 (USD MILLION)
TABLE 61. GLOBAL AUTOMATED PARALLEL PEPTIDE SYNTHESIZER MARKET SIZE, BY 21-50 AMINO ACIDS, BY REGION, 2018-2030 (USD MILLION)
TABLE 62. GLOBAL AUTOMATED PARALLEL PEPTIDE SYNTHESIZER MARKET SIZE, BY MEDIUM PEPTIDES, 2018-2030 (USD MILLION)
TABLE 63. GLOBAL AUTOMATED PARALLEL PEPTIDE SYNTHESIZER MARKET SIZE, BY SHORT PEPTIDES, BY REGION, 2018-2030 (USD MILLION)
TABLE 64. GLOBAL AUTOMATED PARALLEL PEPTIDE SYNTHESIZER MARKET SIZE, BY 2-20 AMINO ACIDS, BY REGION, 2018-2030 (USD MILLION)
TABLE 65. GLOBAL AUTOMATED PARALLEL PEPTIDE SYNTHESIZER MARKET SIZE, BY SHORT PEPTIDES, 2018-2030 (USD MILLION)
TABLE 66. GLOBAL AUTOMATED PARALLEL PEPTIDE SYNTHESIZER MARKET SIZE, BY MODE OF SYNTHESIS, 2018-2030 (USD MILLION)
TABLE 67. GLOBAL AUTOMATED PARALLEL PEPTIDE SYNTHESIZER MARKET SIZE, BY MULTIPLE STEP SYNTHESIS, BY REGION, 2018-2030 (USD MILLION)
TABLE 68. GLOBAL AUTOMATED PARALLEL PEPTIDE SYNTHESIZER MARKET SIZE, BY CONVERGENT COUPLING, BY REGION, 2018-2030 (USD MILLION)
TABLE 69. GLOBAL AUTOMATED PARALLEL PEPTIDE SYNTHESIZER MARKET SIZE, BY SEQUENTIAL COUPLING, BY REGION, 2018-2030 (USD MILLION)
TABLE 70. GLOBAL AUTOMATED PARALLEL PEPTIDE SYNTHESIZER MARKET SIZE, BY MULTIPLE STEP SYNTHESIS, 2018-2030 (USD MILLION)
TABLE 71. GLOBAL AUTOMATED PARALLEL PEPTIDE SYNTHESIZER MARKET SIZE, BY SINGLE STEP SYNTHESIS, BY REGION, 2018-2030 (USD MILLION)
TABLE 72. GLOBAL AUTOMATED PARALLEL PEPTIDE SYNTHESIZER MARKET SIZE, BY RESIN COUPLING, BY REGION, 2018-2030 (USD MILLION)
TABLE 73. GLOBAL AUTOMATED PARALLEL PEPTIDE SYNTHESIZER MARKET SIZE, BY SINGLE STEP SYNTHESIS, 2018-2030 (USD MILLION)
TABLE 74. GLOBAL AUTOMATED PARALLEL PEPTIDE SYNTHESIZER MARKET SIZE, BY PEPTIDE TYPE, 2018-2030 (USD MILLION)
TABLE 75. GLOBAL AUTOMATED PARALLEL PEPTIDE SYNTHESIZER MARKET SIZE, BY CYCLIC PEPTIDES, BY REGION, 2018-2030 (USD MILLION)
TABLE 76. GLOBAL AUTOMATED PARALLEL PEPTIDE SYNTHESIZER MARKET SIZE, BY STAPLED PEPTIDES, BY REGION, 2018-2030 (USD MILLION)
TABLE 77. GLOBAL AUTOMATED PARALLEL PEPTIDE SYNTHESIZER MARKET SIZE, BY CYCLIC PEPTIDES, 2018-2030 (USD MILLION)
TABLE 78. GLOBAL AUTOMATED PARALLEL PEPTIDE SYNTHESIZER MARKET SIZE, BY LINEAR PEPTIDES, BY REGION, 2018-2030 (USD MILLION)
TABLE 79. GLOBAL AUTOMATED PARALLEL PEPTIDE SYNTHESIZER MARKET SIZE, BY UNMODIFIED LINEAR PEPTIDES, BY REGION, 2018-2030 (USD MILLION)
TABLE 80. GLOBAL AUTOMATED PARALLEL PEPTIDE SYNTHESIZER MARKET SIZE, BY LINEAR PEPTIDES, 2018-2030 (USD MILLION)
TABLE 81. GLOBAL AUTOMATED PARALLEL PEPTIDE SYNTHESIZER MARKET SIZE, BY PEPTIDOMIMETICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 82. GLOBAL AUTOMATED PARALLEL PEPTIDE SYNTHESIZER MARKET SIZE, BY PROTEIN MIMETICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 83. GLOBAL AUTOMATED PARALLEL PEPTIDE SYNTHESIZER MARKET SIZE, BY SMALL MOLECULE MIMETICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 84. GLOBAL AUTOMATED PARALLEL PEPTIDE SYNTHESIZER MARKET SIZE, BY PEPTIDOMIMETICS, 2018-2030 (USD MILLION)
TABLE 85. AMERICAS AUTOMATED PARALLEL PEPTIDE SYNTHESIZER MARKET SIZE, BY END USER INDUSTRY, 2018-2030 (USD MILLION)
TABLE 86. AMERICAS AUTOMATED PARALLEL PEPTIDE SYNTHESIZER MARKET SIZE, BY ACADEMIC INSTITUTIONS, 2018-2030 (USD MILLION)
TABLE 87. AMERICAS AUTOMATED PARALLEL PEPTIDE SYNTHESIZER MARKET SIZE, BY PHARMACEUTICAL COMPANIES, 2018-2030 (USD MILLION)
TABLE 88. AMERICAS AUTOMATED PARALLEL PEPTIDE SYNTHESIZER MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
TABLE 89. AMERICAS AUTOMATED PARALLEL PEPTIDE SYNTHESIZER MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2030 (USD MILLION)
TABLE 90. AMERICAS AUTOMATED PARALLEL PEPTIDE SYNTHESIZER MARKET SIZE, BY LIQUID PHASE PEPTIDE SYNTHESIS, 2018-2030 (USD MILLION)
TABLE 91. AMERICAS AUTOMATED PARALLEL PEPTIDE SYNTHESIZER MARKET SIZE, BY SOLID PHASE PEPTIDE SYNTHESIS, 2018-2030 (USD MILLION)
TABLE 92. AMERICAS AUTOMATED PARALLEL PEPTIDE SYNTHESIZER MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 93. AMERICAS AUTOMATED PARALLEL PEPTIDE SYNTHESIZER MARKET SIZE, BY DIAGNOSTIC PEPTIDES, 2018-2030 (USD MILLION)
TABLE 94. AMERICAS AUTOMATED PARALLEL PEPTIDE SYNTHESIZER MARKET SIZE, BY RESEARCH PEPTIDES, 2018-2030 (USD MILLION)
TABLE 95. AMERICAS AUTOMATED PARALLEL PEPTIDE SYNTHESIZER MARKET SIZE, BY THERAPEUTIC PEPTIDES, 2018-2030 (USD MILLION)
TABLE 96. AMERICAS AUTOMATED PARALLEL PEPTIDE SYNTHESIZER MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 97. AMERICAS AUTOMATED PARALLEL PEPTIDE SYNTHESIZER MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 98. AMERICAS AUTOMATED PARALLEL PEPTIDE SYNTHESIZER MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 99. AMERICAS AUTOMATED PARALLEL PEPTIDE SYNTHESIZER MARKET SIZE, BY PEPTIDE LENGTH, 2018-2030 (USD MILLION)
TABLE 100. AMERICAS AUTOMATED PARALLEL PEPTIDE SYNTHESIZER MARKET SIZE, BY LONG PEPTIDES, 2018-2030 (USD MILLION)
TABLE 101. AMERICAS AUTOMATED PARALLEL PEPTIDE SYNTHESIZER MARKET SIZE, BY MEDIUM PEPTIDES, 2018-2030 (USD MILLION)
TABLE 102. AMERICAS AUTOMATED PARALLEL PEPTIDE SYNTHESIZER MARKET SIZE, BY SHORT PEPTIDES, 2018-2030 (USD MILLION)
TABLE 103. AMERICAS AUTOMATED PARALLEL PEPTIDE SYNTHESIZER MARKET SIZE, BY MODE OF SYNTHESIS, 2018-2030 (USD MILLION)
TABLE 104. AMERICAS AUTOMATED PARALLEL PEPTIDE SYNTHESIZER MARKET SIZE, BY MULTIPLE STEP SYNTHESIS, 2018-2030 (USD MILLION)
TABLE 105. AMERICAS AUTOMATED PARALLEL PEPTIDE SYNTHESIZER MARKET SIZE, BY SINGLE STEP SYNTHESIS, 2018-2030 (USD MILLION)
TABLE 106. AMERICAS AUTOMATED PARALLEL PEPTIDE SYNTHESIZER MARKET SIZE, BY PEPTIDE TYPE, 2018-2030 (USD MILLION)
TABLE 107. AMERICAS AUTOMATED PARALLEL PEPTIDE SYNTHESIZER MARKET SIZE, BY CYCLIC PEPTIDES, 2018-2030 (USD MILLION)
TABLE 108. AMERICAS AUTOMATED PARALLEL PEPTIDE SYNTHESIZER MARKET SIZE, BY LINEAR PEPTIDES, 2018-2030 (USD MILLION)
TABLE 109. AMERICAS AUTOMATED PARALLEL PEPTIDE SYNTHESIZER MARKET SIZE, BY PEPTIDOMIMETICS, 2018-2030 (USD MILLION)
TABLE 110. AMERICAS AUTOMATED PARALLEL PEPTIDE SYNTHESIZER MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 111. ARGENTINA AUTOMATED PARALLEL PEPTIDE SYNTHESIZER MARKET SIZE, BY END USER INDUSTRY, 2018-2030 (USD MILLION)
TABLE 112. ARGENTINA AUTOMATED PARALLEL PEPTIDE SYNTHESIZER MARKET SIZE, BY ACADEMIC INSTITUTIONS, 2018-2030 (USD MILLION)
TABLE 113. ARGENTINA AUTOMATED PARALLEL PEPTIDE SYNTHESIZER MARKET SIZE, BY PHARMACEUTICAL COMPANIES, 2018-2030 (USD MILLION)
TABLE 114. ARGENTINA AUTOMATED PARALLEL PEPTIDE SYNTHESIZER MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
TABLE 115. ARGENTINA AUTOMATED PARALLEL PEPTIDE SYNTHESIZER MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2030 (USD MILLION)
TABLE 116. ARGENTINA AUTOMATED PARALLEL PEPTIDE SYNTHESIZER MARKET SIZE, BY LIQUID PHASE PEPTIDE SYNTHESIS, 2018-2030 (USD MILLION)
TABLE 117. ARGENTINA AUTOMATED PARALLEL PEPTIDE SYNTHESIZER MARKET SIZE, BY SOLID PHASE PEPTIDE SYNTHESIS, 2018-2030 (USD MILLION)
TABLE 118. ARGENTINA AUTOMATED PARALLEL PEPTIDE SYNTHESIZER MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 119. ARGENTINA AUTOMATED PARALLEL PEPTIDE SYNTHESIZER MARKET SIZE, BY DIAGNOSTIC PEPTIDES, 2018-2030 (USD MILLION)
TABLE 120. ARGENTINA AUTOMATED PARALLEL PEPTIDE SYNTHESIZER MARKET SIZE, BY RESEARCH PEPTIDES, 2018-2030 (USD MILLION)
TABLE 121. ARGENTINA AUTOMATED PARALLEL PEPTIDE SYNTHESIZER MARKET SIZE, BY THERAPEUTIC PEPTIDES, 2018-2030 (USD MILLION)
TABLE 122. ARGENTINA AUTOMATED PARALLEL PEPTIDE SYNTHESIZER MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 123. ARGENTINA AUTOMATED PARALLEL PEPTIDE SYNTHESIZER MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 124. ARGENTINA AUTOMATED PARALLEL PEPTIDE SYNTHESIZER MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 125. ARGENTINA AUTOMATED PARALLEL PEPTIDE SYNTHESIZER MARKET SIZE, BY PEPTIDE LENGTH, 2018-2030 (USD MILLION)
TABLE 126. ARGENTINA AUTOMATED PARALLEL PEPTIDE SYNTHESIZER MARKET SIZE, BY LONG PEPTIDES, 2018-2030 (USD MILLION)
TABLE 127. ARGENTINA AUTOMATED PARALLEL PEPTIDE SYNTHESIZER MARKET SIZE, BY MEDIUM PEPTIDES, 2018-2030 (USD MILLION)
TABLE 128. ARGENTINA AUTOMATED PARALLEL PEPTIDE SYNTHESIZER MARKET SIZE, BY SHORT PEPTIDES, 2018-2030 (USD MILLION)
TABLE 129. ARGENTINA AUTOMATED PARALLEL PEPTIDE SYNTHESIZER MARKET SIZE, BY MODE OF SYNTHESIS, 2018-2030 (USD MILLION)
TABLE 130. ARGENTINA AUTOMATED PARALLEL PEPTIDE SYNTHESIZER MARKET SIZE, BY MULTIPLE STEP SYNTHESIS, 2018-2030 (USD MILLION)
TABLE 131. ARGENTINA AUTOMATED PARALLEL PEPTIDE SYNTHESIZER MARKET SIZE, BY SINGLE STEP SYNTHESIS, 2018-2030 (USD MILLION)
TABLE 132. ARGENTINA AUTOMATED PARALLEL PEPTIDE SYNTHESIZER MARKET SIZE, BY PEPTIDE TYPE, 2018-2030 (USD MILLION)
TABLE 133. ARGENTINA AUTOMATED PARALLEL PEPTIDE SYNTHESIZER MARKET SIZE, BY CYCLIC PEPTIDES, 2018-2030 (USD MILLION)
TABLE 134. ARGENTINA AUTOMATED PARALLEL PEPTIDE SYNTHESIZER MARKET SIZE, BY LINEAR PEPTIDES, 2018-2030 (USD MILLION)
TABLE 135. ARGENTINA AUTOMATED PARALLEL PEPTIDE SYNTHESIZER MARKET SIZE, BY PEPTIDOMIMETICS, 2018-2030 (USD MILLION)
TABLE 136. BRAZIL AUTOMATED PARALLEL PEPTIDE SYNTHESIZER MARKET SIZE, BY END USER INDUSTRY, 2018-2030 (USD MILLION)
TABLE 137. BRAZIL AUTOMATED PARALLEL PEPTIDE SYNTHESIZER MARKET SIZE, BY ACADEMIC INSTITUTIONS, 2018-2030 (USD MILLION)
TABLE 138. BRAZIL AUTOMATED PARALLEL PEPTIDE SYNTHESIZER MARKET SIZE, BY PHARMACEUTICAL COMPANIES, 2018-2030 (USD MILLION)
TABLE 139. BRAZIL AUTOMATED PARALLEL PEPTIDE SYNTHESIZER MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
TABLE 140. BRAZIL AUTOMATED PARALLEL PEPTIDE SYNTHESIZER MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2030 (USD MILLION)
TABLE 141. BRAZIL AUTOMATED PARALLEL PEPTIDE SYNTHESIZER MARKET SIZE, BY LIQUID PHASE PEPTIDE SYNTHESIS, 2018-2030 (USD MILLION)
TABLE 142. BRAZIL AUTOMATED PARALLEL PEPTIDE SYNTHESIZER MARKET SIZE, BY SOLID PHASE PEPTIDE SYNTHESIS, 2018-2030 (USD MILLION)
TABLE 143. BRAZIL AUTOMATED PARALLEL PEPTIDE SYNTHESIZER MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 144. BRAZIL AUTOMATED PARALLEL PEPTIDE SYNTHESIZER MARKET SIZE, BY DIAGNOSTIC PEPTIDES, 2018-2030 (USD MILLION)
TABLE 145. BRAZIL AUTOMATED PARALLEL PEPTIDE SYNTHESIZER MARKET SIZE, BY RESEARCH PEPTIDES, 2018-2030 (USD MILLION)
TABLE 146. BRAZIL AUTOMATED PARALLEL PEPTIDE SYNTHESIZER MARKET SIZE, BY THERAPEUTIC PEPTIDES, 2018-2030 (USD MILLION)
TABLE 147. BRAZIL AUTOMATED PARALLEL PEPTIDE SYNTHESIZER MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 148. BRAZIL AUTOMATED PARALLEL PEPTIDE SYNTHESIZER MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 149. BRAZIL AUTOMATED PARALLEL PEPTIDE SYNTHESIZER MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 150. BRAZIL AUTOMATED PARALLEL PEPTIDE SYNTHESIZER MARKET SIZE, BY PEPTIDE LENGTH, 2018-2030 (USD MILLION)
TABLE 151. BRAZIL AUTOMATED PARALLEL PEPTIDE SYNTHESIZER MARKET SIZE, BY LONG PEPTIDES, 2018-2030 (USD MILLION)
TABLE 152. BRAZIL AUTOMATED PARALLEL PEPTIDE SYNTHESIZER MARKET SIZE, BY MEDIUM PEPTIDES, 2018-2030 (USD MILLION)
TABLE 153. BRAZIL AUTOMATED PARALLEL PEPTIDE SYNTHESIZER MARKET SIZE, BY SHORT PEPTIDES, 2018-2030 (USD MILLION)
TABLE 154. BRAZIL AUTOMATED PARALLEL PEPTIDE SYNTHESIZER MARKET SIZE, BY MODE OF SYNTHESIS, 2018-2030 (USD MILLION)
TABLE 155. BRAZIL AUTOMATED PARALLEL PEPTIDE SYNTHESIZER MARKET SIZE, BY MULTIPLE STEP SYNTHESIS, 2018-2030 (USD MILLION)
TABLE 156. BRAZIL AUTOMATED PARALLEL PEPTIDE SYNTHESIZER MARKET SIZE, BY SINGLE STEP SYNTHESIS, 2018-2030 (USD MILLION)
TABLE 157. BRAZIL AUTOMATED PARALLEL PEPTIDE SYNTHESIZER MARKET SIZE, BY PEPTIDE TYPE, 2018-2030 (USD MILLION)
TABLE 158. BRAZIL AUTOMATED PARALLEL PEPTIDE SYNTHESIZER MARKET SIZE, BY CYCLIC PEPTIDES, 2018-2030 (USD MILLION)
TABLE 159. BRAZIL AUTOMATED PARALLEL PEPTIDE SYNTHESIZER MARKET SIZE, BY LINEAR PEPTIDES, 2018-2030 (USD MILLION)
TABLE 160. BRAZIL AUTOMATED PARALLEL PEPTIDE SYNTHESIZER MARKET SIZE, BY PEPTIDOMIMETICS, 2018-2030 (USD MILLION)
TABLE 161. CANADA AUTOMATED PARALLEL PEPTIDE SYNTHESIZER MARKET SIZE, BY END USER INDUSTRY, 2018-2030 (USD MILLION)
TABLE 162. CANADA AUTOMATED PARALLEL PEPTIDE SYNTHESIZER MARKET SIZE, BY ACADEMIC INSTITUTIONS, 2018-2030 (USD MILLION)
TABLE 163. CANADA AUTOMATED PARALLEL PEPTIDE SYNTHESIZER MARKET SIZE, BY PHARMACEUTICAL COMPANIES, 2018-2030 (USD MILLION)
TABLE 164. CANADA AUTOMATED PARALLEL PEPTIDE SYNTHESIZER MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
TABLE 165. CANADA AUTOMATED PARALLEL PEPTIDE SYNTHESIZER MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2030 (USD MILLION)
TABLE 166. CANADA AUTOMATED PARALLEL PEPTIDE SYNTHESIZER MARKET SIZE, BY LIQUID PHASE PEPTIDE SYNTHESIS, 2018-2030 (USD MILLION)
TABLE 167. CANADA AUTOMATED PARALLEL PEPTIDE SYNTHESIZER MARKET SIZE, BY SOLID PHASE PEPTIDE SYNTHESIS, 2018-2030 (USD MILLION)
TABLE 168. CANADA AUTOMATED PARALLEL PEPTIDE SYNTHESIZER MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 169. CANADA AUTOMATED PARALLEL PEPTIDE SYNTHESIZER MARKET SIZE, BY DIAGNOSTIC PEPTIDES, 2018-2030 (USD MILLION)
TABLE 170. CANADA AUTOMATED PARALLEL PEPTIDE SYNTHESIZER MARKET SIZE, BY RESEARCH PEPTIDES, 2018-2030 (USD MILLION)
TABLE 171. CANADA AUTOMATED PARALLEL PEPTIDE SYNTHESIZER MARKET SIZE, BY THERAPEUTIC PEPTIDES, 2018-2030 (USD MILLION)
TABLE 172. CANADA AUTOMATED PARALLEL PEPTIDE SYNTHESIZER MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 173. CANADA AUTOMATED PARALLEL PEPTIDE SYNTHESIZER MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 174. CANADA AUTOMATED PARALLEL PEPTIDE SYNTHESIZER MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 175. CANADA AUTOMATED PARALLEL PEPTIDE SYNTHESIZER MARKET SIZE, BY PEPTIDE LENGTH, 2018-2030 (USD MILLION)
TABLE 176. CANADA AUTOMATED PARALLEL PEPTIDE SYNTHESIZER MARKET SIZE, BY LONG PEPTIDES, 2018-2030 (USD MILLION)
TABLE 177. CANADA AUTOMATED PARALLEL PEPTIDE SYNTHESIZER MARKET SIZE, BY MEDIUM PEPTIDES, 2018-2030 (USD MILLION)
TABLE 178. CANADA AUTOMATED PARALLEL PEPTIDE SYNTHESIZER MARKET SIZE, BY SHORT PEPTIDES, 2018-2030 (USD MILLION)
TABLE 179. CANADA AUTOMATED PARALLEL PEPTIDE SYNTHESIZER MARKET SIZE, BY MODE OF SYNTHESIS, 2018-2030 (USD MILLION)
TABLE 180. CANADA AUTOMATED PARALLEL PEPTIDE SYNTHESIZER MARKET SIZE, BY MULTIPLE STEP SYNTHESIS, 2018-2030 (USD MILLION)
TABLE 181. CANADA AUTOMATED PARALLEL PEPTIDE SYNTHESIZER MARKET SIZE, BY SINGLE STEP SYNTHESIS, 2018-2030 (USD MILLION)
TABLE 182. CANADA AUTOMATED PARALLEL PEPTIDE SYNTHESIZER MARKET SIZE, BY PEPTIDE TYPE, 2018-2030 (USD MILLION)
TABLE 183. CANADA AUTOMATED PARALLEL PEPTIDE SYNTHESIZER MARKET SIZE, BY CYCLIC PEPTIDES, 2018-2030 (USD MILLION)
TABLE 184. CANADA AUTOMATED PARALLEL PEPTIDE SYNTHESIZER MARKET SIZE, BY LINEAR PEPTIDES, 2018-2030 (USD MILLION)
TABLE 185. CANADA AUTOMATED PARALLEL PEPTIDE SYNTHESIZER MARKET SIZE, BY PEPTIDOMIMETICS, 2018-2030 (USD MILLION)
TABLE 186. MEXICO AUTOMATED PARALLEL PEPTIDE SYNTHESIZER MARKET SIZE, BY END USER INDUSTRY, 2018-2030 (USD MILLION)
TABLE 187. MEXICO AUTOMATED PARALLEL PEPTIDE SYNTHESIZER MARKET SIZE, BY ACADEMIC INSTITUTIONS, 2018-2030 (USD MILLION)
TABLE 188. MEXICO AUTOMATED PARALLEL PEPTIDE SYNTHESIZER MARKET SIZE, BY PHARMACEUTICAL COMPANIES, 2018-2030 (USD MILLION)
TABLE 189. MEXICO AUTOMATED PARALLEL PEPTIDE SYNTHESIZER MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
TABLE 190. MEXICO AUTOMATED PARALLEL PEPTIDE SYNTHESIZER MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2030 (USD MILLION)
TABLE 191. MEXICO AUTOMATED PARALLEL PEPTIDE SYNTHESIZER MARKET SIZE, BY LIQUID PHASE PEPTIDE SYNTHESIS, 2018-2030 (USD MILLION)
TABLE 192. MEXICO AUTOMATED PARALLEL PEPTIDE SYNTHESIZER MARKET SIZE, BY SOLID PHASE PEPTIDE SYNTHESIS, 2018-2030 (USD MILLION)
TABLE 193. MEXICO AUTOMATED PARALLEL PEPTIDE SYNTHESIZER MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 194. MEXICO AUTOMATED PARALLEL PEPTIDE SYNTHESIZER MARKET SIZE, BY DIAGNOSTIC PEPTIDES, 2018-2030 (USD MILLION)
TABLE 195. MEXICO AUTOMATED PARALLEL PEPTIDE SYNTHESIZER MARKET SIZE, BY RESEARCH PEPTIDES, 2018-2030 (USD MILLION)
TABLE 196. MEXICO AUTOMATED PARALLEL PEPTIDE SYNTHESIZER MARKET SIZE, BY THERAPEUTIC PEPTIDES, 2018-2030 (USD MILLION)
TABLE 197. MEXICO AUTOMATED PARALLEL PEPTIDE SYNTHESIZER MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 198. MEXICO AUTOMATED PARALLEL PEPTIDE SYNTHESIZER MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 199. MEXICO AUTOMATED PARALLEL PEPTIDE SYNTHESIZER MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 200. MEXICO AUTOMATED PARALLEL PEPTIDE SYNTHESIZER MARKET SIZE, BY PEPTIDE LENGTH, 2018-2030 (USD MILLION)
TABLE 201. MEXICO AUTOMATED PARALLEL PEPTIDE SYNTHESIZER MARKET SIZE, BY LONG PEPTIDES, 2018-2030 (USD MILLION)
TABLE 202. MEXICO AUTOMATED PARALLEL PEPTIDE SYNTHESIZER MARKET SIZE, BY MEDIUM PEPTIDES, 2018-2030 (USD MILLION)
TABLE 203. MEXICO AUTOMATED PARALLEL PEPTIDE SYNTHESIZER MARKET SIZE, BY SHORT PEPTIDES, 2018-2030 (USD MILLION)
TABLE 204. MEXICO AUTOMATED PARALLEL PEPTIDE SYNTHESIZER MARKET SIZE, BY MODE OF SYNTHESIS, 2018-2030 (USD MILLION)
TABLE 205. MEXICO AUTOMATED PARALLEL PEPTIDE SYNTHESIZER MARKET SIZE, BY MULTIPLE STEP SYNTHESIS, 2018-2030 (USD MILLION)
TABLE 206. MEXICO AUTOMATED PARALLEL PEPTIDE SYNTHESIZER MARKET SIZE, BY SINGLE STEP SYNTHESIS, 2018-2030 (USD MILLION)
TABLE 207. MEXICO AUTOMATED PARALLEL PEPTIDE SYNTHESIZER MARKET SIZE, BY PEPTIDE TYPE, 2018-2030 (USD MILLION)
TABLE 208. MEXICO AUTOMATED PARALLEL PEPTIDE SYNTHESIZER MARKET SIZE, BY CYCLIC PEPTIDES, 2018-2030 (USD MILLION)
TABLE 209. MEXICO AUTOMATED PARALLEL PEPTIDE SYNTHESIZER MARKET SIZE, BY LINEAR PEPTIDES, 2018-2030 (USD MILLION)
TABLE 210. MEXICO AUTOMATED PARALLEL PEPTIDE SYNTHESIZER MARKET SIZE, BY PEPTIDOMIMETICS, 2018-2030 (USD MILLION)
TABLE 211. UNITED STATES AUTOMATED PARALLEL PEPTIDE SYNTHESIZER MARKET SIZE, BY END USER INDUSTRY, 2018-2030 (USD MILLION)
TABLE 212. UNITED STATES AUTOMATED PARALLEL PEPTIDE SYNTHESIZER MARKET SIZE, BY ACADEMIC INSTITUTIONS, 2018-2030 (USD MILLION)
TABLE 213. UNITED STATES AUTOMATED PARALLEL PEPTIDE SYNTHESIZER MARKET SIZE, BY PHARMACEUTICAL COMPANIES, 2018-2030 (USD MILLION)
TABLE 214. UNITED STATES AUTOMATED PARALLEL PEPTIDE SYNTHESIZER MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
TABLE 215. UNITED STATES AUTOMATED PARALLEL PEPTIDE SYNTHESIZER MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2030 (USD MILLION)
TABLE 216. UNITED STATES AUTOMATED PARALLEL PEPTIDE SYNTHESIZER MARKET SIZE, BY LIQUID PHASE PEPTIDE SYNTHESIS, 2018-2030 (USD MILLION)
TABLE 217. UNITED STATES AUTOMATED PARALLEL PEPTIDE SYNTHESIZER MARKET SIZE, BY SOLID PHASE PEPTIDE SYNTHESIS, 2018-2030 (USD MILLION)
TABLE 218. UNITED STATES AUTOMATED PARALLEL PEPTIDE SYNTHESIZER MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 219. UNITED STATES AUTOMATED PARALLEL PEPTIDE SYNTHESIZER MARKET SIZE, BY DIAGNOSTIC PEPTIDES, 2018-2030 (USD MILLION)
TABLE 220. UNITED STATES AUTOMATED PARALLEL PEPTIDE SYNTHESIZER MARKET SIZE, BY RESEARCH PEPTIDES, 2018-2030 (USD MILLION)
TABLE 221. UNITED STATES AUTOMATED PARALLEL PEPTIDE SYNTHESIZER MARKET SIZE, BY THERAPEUTIC PEPTIDES, 2018-2030 (USD MILLION)
TABLE 222. UNITED STATES AUTOMATED PARALLEL PEPTIDE SYNTHESIZER MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 223. UNITED STATES AUTOMATED PARALLEL PEPTIDE SYNTHESIZER MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 224. UNITED STATES AUTOMATED PARALLEL PEPTIDE SYNTHESIZER MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 225. UNITED STATES AUTOMATED PARALLEL PEPTIDE SYNTHESIZER MARKET SIZE, BY PEPTIDE LENGTH, 2018-2030 (USD MILLION)
TABLE 226. UNITED STATES AUTOMATED PARALLEL PEPTIDE SYNTHESIZER MARKET SIZE, BY LONG PEPTIDES, 2018-2030 (USD MILLION)
TABLE 227. UNITED STATES AUTOMATED PARALLEL PEPTIDE SYNTHESIZER MARKET SIZE, BY MEDIUM PEPTIDES, 2018-2030 (USD MILLION)
TABLE 228. UNITED STATES AUTOMATED PARALLEL PEPTIDE SYNTHESIZER MARKET SIZE, BY SHORT PEPTIDES, 2018-2030 (USD MILLION)
TABLE 229. UNITED STATES AUTOMATED PARALLEL PEPTIDE SYNTHESIZER MARKET SIZE, BY MODE OF SYNTHESIS, 2018-2030 (USD MILLION)
TABLE 230. UNITED STATES AUTOMATED PARALLEL PEPTIDE SYNTHESIZER MARKET SIZE, BY MULTIPLE STEP SYNTHESIS, 2018-2030 (USD MILLION)
TABLE 231. UNITED STATES AUTOMATED PARALLEL PEPTIDE SYNTHESIZER MARKET SIZE, BY SINGLE STEP SYNTHESIS, 2018-2030 (USD MILLION)
TABLE 232. UNITED STATES AUTOMATED PARALLEL PEPTIDE SYNTHESIZER MARKET SIZE, BY PEPTIDE TYPE, 2018-2030 (USD MILLION)
TABLE 233. UNITED STATES AUTOMATED PARALLEL PEPTIDE SYNTHESIZER MARKET SIZE, BY CYCLIC PEPTIDES, 2018-2030 (USD MILLION)
TABLE 234. UNITED STATES AUTOMATED PARALLEL PEPTIDE SYNTHESIZER MARKET SIZE, BY LINEAR PEPTIDES, 2018-2030 (USD MILLION)
TABLE 235. UNITED STATES AUTOMATED PARALLEL PEPTIDE SYNTHESIZER MARKET SIZE, BY PEPTIDOMIMETICS, 2018-2030 (USD MILLION)
TABLE 236. UNITED STATES AUTOMATED PARALLEL PEPTIDE SYNTHESIZER MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 237. ASIA-PACIFIC AUTOMATED PARALLEL PEPTIDE SYNTHESIZER MARKET SIZE, BY END USER INDUSTRY, 2018-2030 (USD MILLION)
TABLE 238. ASIA-PACIFIC AUTOMATED PARALLEL PEPTIDE SYNTHESIZER MARKET SIZE, BY ACADEMIC INSTITUTIONS, 2018-2030 (USD MILLION)
TABLE 239. ASIA-PACIFIC AUTOMATED PARALLEL PEPTIDE SYNTHESIZER MARKET SIZE, BY PHARMACEUTICAL COMPANIES, 2018-2030 (USD MILLION)
TABLE 240. ASIA-PACIFIC AUTOMATED PARALLEL PEPTIDE SYNTHESIZER MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
TABLE 241. ASIA-PACIFIC AUTOMATED PARALLEL PEPTIDE SYNTHESIZER MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2030 (USD MILLION)
TABLE 242. ASIA-PACIFIC AUTOMATED PARALLEL PEPTIDE SYNTHESIZER MARKET SIZE, BY LIQUID PHASE PEPTIDE SYNTHESIS, 2018-2030 (USD MILLION)
TABLE 243. ASIA-PACIFIC AUTOMATED PARALLEL PEPTIDE SYNTHESIZER MARKET SIZE, BY SOLID PHASE PEPTIDE SYNTHESIS, 2018-2030 (USD MILLION)
TABLE 244. ASIA-PACIFIC AUTOMATED PARALLEL PEPTIDE SYNTHESIZER MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 245. ASIA-PACIFIC AUTOMATED PARALLEL PEPTIDE SYNTHESIZER MARKET SIZE, BY DIAGNOSTIC PEPTIDES, 2018-2030 (USD MILLION)
TABLE 246. ASIA-PACIFIC AUTOMATED PARALLEL PEPTIDE SYNTHESIZER MARKET SIZE, BY RESEARCH PEPTIDES, 2018-2030 (USD MILLION)
TABLE 247. ASIA-PACIFIC AUTOMATED PARALLEL PEPTIDE SYNTHESIZER MARKET SIZE, BY THERAPEUTIC PEPTIDES, 2018-2030 (USD MILLION)
TABLE 248. ASIA-PACIFIC AUTOMATED PARALLEL PEPTIDE SYNTHESIZER MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 249. ASIA-PACIFIC AUTOMATED PARALLEL PEPTIDE SYNTHESIZER MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 250. ASIA-PACIFIC AUTOMATED PARALLEL PEPTIDE SYNTHESIZER MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 251. ASIA-PACIFIC AUTOMATED PARALLEL PEPTIDE SYNTHESIZER MARKET SIZE, BY PEPTIDE LENGTH, 2018-2030 (USD MILLION)
TABLE 252. ASIA-PACIFIC AUTOMATED PARALLEL PEPTIDE SYNTHESIZER MARKET SIZE, BY LONG PEPTIDES, 2018-2030 (USD MILLION)
TABLE 253. ASIA-PACIFIC AUTOMATED PARALLEL PEPTIDE SYNTHESIZER MARKET SIZE, BY MEDIUM PEPTIDES, 2018-2030 (USD MILLION)
TABLE 254. ASIA-PACIFIC AUTOMATED PARALLEL PEPTIDE SYNTHESIZER MARKET SIZE, BY SHORT PEPTIDES, 2018-2030 (USD MILLION)
TABLE 255. ASIA-PACIFIC AUTOMATED PARALLEL PEPTIDE SYNTHESIZER MARKET SIZE, BY MODE OF SYNTHESIS, 2018-2030 (USD MILLION)
TABLE 256. ASIA-PACIFIC AUTOMATED PARALLEL PEPTIDE SYNTHESIZER MARKET SIZE, BY MULTIPLE STEP SYNTHESIS, 2018-2030 (USD MILLION)
TABLE 257. ASIA-PACIFIC AUTOMATED PARALLEL PEPTIDE SYNTHESIZER MARKET SIZE, BY SINGLE STEP SYNTHESIS, 2018-2030 (USD MILLION)
TABLE 258. ASIA-PACIFIC AUTOMATED PARALLEL PEPTIDE SYNTHESIZER MARKET SIZE, BY PEPTIDE TYPE, 2018-2030 (USD MILLION)
TABLE 259. ASIA-PACIFIC AUTOMATED PARALLEL PEPTIDE SYNTHESIZER MARKET SIZE, BY CYCLIC PEPTIDES, 2018-2030 (USD MILLION)
TABLE 260. ASIA-PACIFIC AUTOMATED PARALLEL PEPTIDE SYNTHESIZER MARKET SIZE, BY LINEAR PEPTIDES, 2018-2030 (USD MILLION)
TABLE 261. ASIA-PACIFIC AUTOMATED PARALLEL PEPTIDE SYNTHESIZER MARKET SIZE, BY PEPTIDOMIMETICS, 2018-2030 (USD MILLION)
TABLE 262. ASIA-PACIFIC AUTOMATED PARALLEL PEPTIDE SYNTHESIZER MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 263. AUSTRALIA AUTOMATED PARALLEL PEPTIDE SYNTHESIZER MARKET SIZE, BY END USER INDUSTRY, 2018-2030 (USD MILLION)
TABLE 264. AUSTRALIA AUTOMATED PARALLEL PEPTIDE SYNTHESIZER MARKET SIZE, BY ACADEMIC INSTITUTIONS, 2018-2030 (USD MILLION)
TABLE 265. AUSTRALIA AUTOMATED PARALLEL PEPTIDE SYNTHESIZER MARKET SIZE, BY PHARMACEUTICAL COMPANIES, 2018-2030 (USD MILLION)
TABLE 266. AUSTRALIA AUTOMATED PARALLEL PEPTIDE SYNTHESIZER MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
TABLE 267. AUSTRALIA AUTOMATED PARALLEL PEPTIDE SYNTHESIZER MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2030 (USD MILLION)
TABLE 268. AUSTRALIA AUTOMATED PARALLEL PEPTIDE SYNTHESIZER MARKET SIZE, BY LIQUID PHASE PEPTIDE SYNTHESIS, 2018-2030 (USD MILLION)
TABLE 269. AUSTRALIA AUTOMATED PARALLEL PEPTIDE SYNTHESIZER MARKET SIZE, BY SOLID PHASE PEPTIDE SYNTHESIS, 2018-2030 (USD MILLION)
TABLE 270. AUSTRALIA AUTOMATED PARALLEL PEPTIDE SYNTHESIZER MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 271. AUSTRALIA AUTOMATED PARALLEL PEPTIDE SYNTHESIZER MARKET SIZE, BY DIAGNOSTIC PEPTIDES, 2018-2030 (USD MILLION)
TABLE 272. AUSTRALIA AUTOMATED PARALLEL PEPTIDE SYNTHESIZER MARKET SIZE, BY RESEARCH PEPTIDES, 2018-2030 (USD MILLION)
TABLE 273. AUSTRALIA AUTOMATED PARALLEL PEPTIDE SYNTHESIZER MARKET SIZE, BY THERAPEUTIC PEPTIDES, 2018-2030 (USD MILLION)
TABLE 274. AUSTRALIA AUTOMATED PARALLEL PEPTIDE SYNTHESIZER MARKET SIZE, BY PRODUCT TYPE,

Companies Mentioned

  • AAPPTec
  • Advanced ChemTech
  • AG Scientific
  • AminoTech SA
  • BGI Genomics
  • Biotage
  • CEM Corporation
  • CS Bio
  • EMD Millipore
  • GenScript Biotech Corporation
  • Gilson Inc.
  • Gyros Protein Technologies
  • Intavis Bioanalytical Instruments AG
  • JPT Peptide Technologies
  • Kinexus Bioinformatics Corporation
  • Peptides International Inc.
  • PSI (Protein Synthesizer Inc.)
  • Sartorius Stedim Biotech
  • Thermo Fisher Scientific

Methodology

Loading
LOADING...

Related Topics

Related Reports

Peptide Synthesis - Global Strategic Business Report - Product Image

Peptide Synthesis - Global Strategic Business Report

  • Report
  • 184 Pages
  • Global
From
Peptide Synthesis Market by Reagents (Resins, Amino Acid, Dyes), Instruments (Peptide Synthesizer, Chromatography, Lyophilizer), Technique (Solid-Phase, Solution-Phase, Hybrid), Services, Application (Therapeutics), End User - Global Forecast to 2029 - Product Image

Peptide Synthesis Market by Reagents (Resins, Amino Acid, Dyes), Instruments (Peptide Synthesizer, Chromatography, Lyophilizer), Technique (Solid-Phase, Solution-Phase, Hybrid), Services, Application (Therapeutics), End User - Global Forecast to 2029

  • Report
  • 564 Pages
  • Global
From
Peptide Synthesizer Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Product Type - Product Image

Peptide Synthesizer Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Product Type

  • Report
  • 94 Pages
  • Global
From
Automatic Parallel Peptide Synthesiser Market - Global Forecast to 2030 - Product Image

Automatic Parallel Peptide Synthesiser Market - Global Forecast to 2030

  • Report
  • 198 Pages
  • Global
From
Peptide Synthesis Market by Product Type (Equipment, Reagents & Consumables, Services), Technology (Hybrid Technology, Liquid Phase Peptide Synthesis, Solid Phase Peptide Synthesis), Application, End-User - Global Forecast 2025-2030 - Product Image

Peptide Synthesis Market by Product Type (Equipment, Reagents & Consumables, Services), Technology (Hybrid Technology, Liquid Phase Peptide Synthesis, Solid Phase Peptide Synthesis), Application, End-User - Global Forecast 2025-2030

  • Report
  • 195 Pages
  • Global
From
Copyright © 2002-2025 Research and Markets. All Rights Reserved.